CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 50,000 shares at an average $10.19 ($509,500)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 50,000 shares at an average $10.26 ($512,750)
- 4 Open-market buy Vice President and CFO bought 1,026 shares at $6.50 ($6,669)
- 4 Open-market buy Chief Operating & Med. Officer bought 193 shares at $6.50 ($1,255)
- 4 Open-market sale President and CEO sold 50,000 shares at an average $10.91 ($545,250)
- 4 Open-market sale President and CEO sold 50,000 shares at an average $9.70 ($484,750)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 50,000 shares at an average $9.54 ($476,750)
- 4 Open-market buy 10% owner bought 17,000 shares at an average $8.36 ($142,150)
- 4 Open-market buy 10% owner bought 15,000 shares at an average $8.50 ($127,550)
- 4 Open-market buy 10% owner bought 100 shares at $8.24 ($824)
- 4 Open-market sale President and CEO sold 50,000 shares at an average $8.45 ($422,250)
- 4 Open-market buy 10% owner bought 10,075 shares at $8.34 ($84,026)
- 4 Open-market buy 10% owner bought 7,277 shares at $8.41 ($61,200)
- 4 Open-market buy 10% owner bought 3,390 shares at $8.27 ($28,035)
Page 21 of 30 · 591 filings